Skip to content

Effect of using The Optimal Lymph Flow on prevention of lymphedema after breast cancer surgery

Effect of using The Optimal Lymph Flow on prevention of lymphedema after breast cancer surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016713
Enrollment
Unknown
Registered
2018-06-19
Start date
2018-07-01
Completion date
Unknown
Last updated
2018-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

high dose:High-dose prevention of lymphedema
low dose:Low-dose prevention of lymphedema

Sponsors

West China School of Nursing, West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) non pregnant women with primary treatment; (2) Aged 20-80 years old; (3) preoperative and postoperative pathological examination revealed infiltrating ductal carcinoma or lobular carcinoma of breast; (4) the types of operation include: breast tumor resection, simple mastectomy, breast subcutaneous simple resection plus breast reconstruction, sentinel lymph node dissection biopsy, axillary lymph node dissection; (5) no history of non breast surgery or treatment that could not lead to upper limb edema, such as thoracic surgery, axillary surgery, shoulder surgery, upper limb surgery, and the history of radiation therapy in the above parts; (6) no other chronic diseases that could cause limb edema, such as chronic kidney disease, chronic heart disease, chronic liver disease, hypothyroidism, etc; (7) voluntary participant in this study; (8) have at least 6 of the following symptoms and suffering at the first month after operation (stomach discomfort, self image disorder, change of vision, vomiting, dyspnea, sleep disorders, inattention, irritability, pain, fatigue, eating disorders, constipation, diarrhea, cough, numbness of limbs, burning pain or fatigue, dysphagia or choking, stool incontinence, hearing difficulty, dizziness, sound change, such as hoarseness, memory decline).

Exclusion criteria

Exclusion criteria: (1) There was tumor metastasis at the time of diagnosis; (2) distant metastasis occurred during the study; (3) Patients who will be skin grafted later; (4) Patients with severe mental illness or cognitive impairment who cannot cope with the study.

Design outcomes

Primary

MeasureTime frame
Upper limb volume;Symptomatic experience index of lymphedema in breast cancer;SF-36;

Countries

China

Contacts

Public ContactXianqiong Feng

West China Hospital, Sichuan University

fengxianqiong66@126.com+86 18980601700

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026